수의용 피부과 의약품 시장 규모, 점유율, 성장 분석 : 약물 종류별, 투여 경로별, 동물 종류별, 적응증별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Veterinary Dermatology Drugs Market size was valued at USD 18.1 Billion in 2024 and is poised to grow from USD 19.84 Billion in 2025 to USD 41.3 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The global veterinary dermatology drugs market is thriving due to increasing companion animal ownership and elevated pet health expectations among owners, driving the demand for specialized treatments. This market addresses various skin conditions, including allergic dermatitis and chronic pyoderma, as skin issues are common reasons pets visit vets. Traditional therapies have evolved from general antibiotics to advanced solutions like oclacitinib and monoclonal antibodies, significantly impacting veterinary practices. As pet owners treat their animals as family, their willingness to invest in advanced medical treatments has surged, enticing drug developers. Enhanced diagnostic tools enable precise identification of conditions, promoting the use of targeted therapies and reducing dependence on corticosteroids, while the success of products like oclacitinib demonstrates the opportunity for premium pricing and investment in new markets worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Dermatology Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Dermatology Drugs Market Segments Analysis

Global veterinary dermatology drugs market is segmented by by drug class, by route of administration, by animal type, by indication, by distribution channel, by end user and region. Based on by drug class, the market is segmented into Antibacterial Drugs, Antifungal Drugs, Anti-inflammatory Drugs, Antiparasitic Drugs, Immunomodulators, Antihistamines and Others. Based on by route of administration, the market is segmented into Oral, Topical and Injectable. Based on by animal type, the market is segmented into Companion Animals and Livestock Animals. Based on by indication, the market is segmented into Allergic Dermatitis, Atopic Dermatitis, Bacterial Skin Infections, Fungal Skin Infections, Parasitic Skin Diseases and Others. Based on by distribution channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on by end user, the market is segmented into Veterinary Hospitals, Veterinary Clinics, Animal Shelters, Livestock Farms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Dermatology Drugs Market

The increasing number of pet owners, combined with a cultural shift towards treating companion animals as integral family members, has significantly boosted the demand for advanced veterinary care, particularly in dermatology. Pet owners are increasingly seeking professional diagnoses and ongoing management for chronic skin issues, prompting veterinarians to prescribe specialized topical and systemic treatments more frequently. A heightened willingness to invest in pet health and enhance quality of life drives market growth by fostering the development of innovative products, expanding distribution channels, and encouraging the adoption of new therapeutic options aimed at addressing common dermatological disorders in pets.

Restraints in the Global Veterinary Dermatology Drugs Market

The Global Veterinary Dermatology Drugs market faces significant constraints due to the premium pricing associated with innovative dermatological agents and proprietary formulations, which can restrict access for numerous pet owners. This situation often leads to cost-sensitive veterinary practices being hesitant to prescribe these specialized treatments, ultimately limiting market penetration. The high costs involved in the development and manufacturing processes may result in insufficient reimbursement options, causing veterinarians to be reluctant to endorse long-term treatment plans. When pet owners perceive that the costs outweigh the perceived benefits, they tend to opt for more affordable symptomatic treatments, thereby hampering the adoption of advanced therapies and reducing the overall customer base in the market.

Market Trends of the Global Veterinary Dermatology Drugs Market

The Global Veterinary Dermatology Drugs market is witnessing a notable trend driven by the humanization of companion animals, where pet owners are increasingly seeking advanced dermatological treatments that reflect their own health standards. As expectations rise, the demand for premium topical and systemic options tailored specifically for pets has surged. Responding to this shift, veterinarians and product developers are prioritizing safety, lifestyle compatibility, and improved aesthetic outcomes, thereby integrating quality-of-life considerations into treatment protocols. This trend promotes the expansion of service offerings and fosters collaboration between clinics and specialty manufacturers, resulting in differentiated clinical services and product lines that cater to consumers' desires for comprehensive pet wellness and skin care management.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Dermatology Drugs Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Antibacterial Drugs
  • Topical Antibiotics
  • Systemic Antibiotics
  • Others
• Antifungal Drugs
• Anti-inflammatory Drugs
• Antiparasitic Drugs
• Immunomodulators
• Antihistamines
• Others

Global Veterinary Dermatology Drugs Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Topical
• Injectable

Global Veterinary Dermatology Drugs Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Others
• Livestock Animals
  • Cattle
  • Swine
  • Poultry
  • Others

Global Veterinary Dermatology Drugs Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Allergic Dermatitis
• Atopic Dermatitis
• Bacterial Skin Infections
• Fungal Skin Infections
• Parasitic Skin Diseases
• Others

Global Veterinary Dermatology Drugs Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Others

Global Veterinary Dermatology Drugs Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Animal Shelters
• Livestock Farms
• Others

Global Veterinary Dermatology Drugs Market Size & CAGR (2026-2033)

• North America (By Drug Class, By Route of Administration, By Animal Type, By Indication, By Distribution Channel, By End User)
  • US
  • Canada
• Europe (By Drug Class, By Route of Administration, By Animal Type, By Indication, By Distribution Channel, By End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Drug Class, By Route of Administration, By Animal Type, By Indication, By Distribution Channel, By End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Drug Class, By Route of Administration, By Animal Type, By Indication, By Distribution Channel, By End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Drug Class, By Route of Administration, By Animal Type, By Indication, By Distribution Channel, By End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindred Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetIQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chanelle Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioiberica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurora Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations